147 related articles for article (PubMed ID: 28680334)
1. Expression of CD55, CD59, and CD35 on red blood cells of β-thalassaemia patients.
Kurtoǧllu AU; Koçtekin B; Kurtoǧlu E; Yildiz M; Bozkurt S
Cent Eur J Immunol; 2017; 42(1):78-84. PubMed ID: 28680334
[TBL] [Abstract][Full Text] [Related]
2. The effect of splenectomy on complement regulatory proteins in erythrocytes in β-thalassemia major.
Kurtoğllu AU; Koçtekin B; Kurtoğlu E; Yildiz M
Arch Med Sci; 2019 Jan; 15(1):191-195. PubMed ID: 30697270
[TBL] [Abstract][Full Text] [Related]
3. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.
Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO
Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of complement regulatory proteins (CD35, CD55 and CD59) on peripheral blood cells of patients with chronic kidney disease.
Eldewi DM; Alhabibi AM; El Sayed HME; Mahmoud SAK; El Sadek SM; Gouda RM; Hassan MAEM; Ibrahim AH; Abd El Haliem NF
Int J Gen Med; 2019; 12():343-351. PubMed ID: 31571973
[TBL] [Abstract][Full Text] [Related]
5. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.
Nuutila J; Jalava-Karvinen P; Hohenthal U; Kotilainen P; Pelliniemi TT; Nikoskelainen J; Lilius EM
Hum Immunol; 2013 May; 74(5):522-30. PubMed ID: 23376460
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD55 on red blood cells of β-thalassemia patients.
Obaid JM; Abo El-Nazar SY; Ghanem AM; El-Hadidi AS; Mersal BH
Hemoglobin; 2014; 38(5):339-44. PubMed ID: 25026028
[TBL] [Abstract][Full Text] [Related]
7. The effects of marathon running on expression of the complement regulatory proteins CD55 (DAF) and CD59 (MACIF) on red blood cells.
Simpson RJ; Florida-James GD; Whyte GP; Middleton N; Shave R; George K; Guy K
Eur J Appl Physiol; 2007 Jan; 99(2):201-4. PubMed ID: 17089158
[TBL] [Abstract][Full Text] [Related]
8. Compensation of CD55 Underexpression on Red Blood Cells of β-Thalassemia Major Patients.
Obaid JM; Abo El-Nazar SY; Ghanem AM; El-Hadidi AS; Mersal BH
Hemoglobin; 2015; 39(3):184-9. PubMed ID: 25897480
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).
Watson R; Wearmouth E; McLoughlin AC; Jackson A; Ward S; Bertram P; Bennaceur K; Barker CE; Pappworth IY; Kavanagh D; Lea SM; Atkinson JP; Goodship TH; Marchbank KJ
Mol Immunol; 2015 Feb; 63(2):287-96. PubMed ID: 25150608
[TBL] [Abstract][Full Text] [Related]
10. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
11. Anaemia & expression levels of CD35, CD55 & CD59 on red blood cells in Plasmodium falciparum malaria patients from India.
Mahajan RC; Narain K; Mahanta J
Indian J Med Res; 2011 Jun; 133(6):662-4. PubMed ID: 21727667
[TBL] [Abstract][Full Text] [Related]
12. Different expression and mobilisation of the complement regulatory proteins CD35, CD55 and CD59 in neonatal and adult neutrophils.
Lothian C; Dahlgren C; Lagercrantz H; Lundahl J
Biol Neonate; 1997; 72(1):15-21. PubMed ID: 9313830
[TBL] [Abstract][Full Text] [Related]
13. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
Terstappen LW; Nguyen M; Lazarus HM; Medof ME
J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Complement Regulatory Proteins CD55 and CD59 on Erythrocytes in Beta-Thalassemia Major Patients.
Zahran AM; Shaltout AS; Hamada IH; Mohammed AM; Abo Elgheet AM; Elsayh KI
Egypt J Immunol; 2020 Jan; 27(1):109-118. PubMed ID: 33180393
[TBL] [Abstract][Full Text] [Related]
15. Complement activation in Ghanaian children with severe Plasmodium falciparum malaria.
Helegbe GK; Goka BQ; Kurtzhals JA; Addae MM; Ollaga E; Tetteh JK; Dodoo D; Ofori MF; Obeng-Adjei G; Hirayama K; Awandare GA; Akanmori BD
Malar J; 2007 Dec; 6():165. PubMed ID: 18086298
[TBL] [Abstract][Full Text] [Related]
16. Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis.
Jones J; Laffafian I; Cooper AM; Williams BD; Morgan BP
Br J Rheumatol; 1994 Aug; 33(8):707-12. PubMed ID: 8055195
[TBL] [Abstract][Full Text] [Related]
17. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
D'Cruz OJ; Haas GG
Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
[TBL] [Abstract][Full Text] [Related]
18. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
19. Recombinant EPO therapy increases erythrocyte expression of complement regulatory proteins.
Ohi H; Tamano M; Sudo S; Okada N
Am J Kidney Dis; 2003 Jan; 41(1):179-85. PubMed ID: 12500235
[TBL] [Abstract][Full Text] [Related]
20. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
